The potential usefulness of serum melatonin level to predict heart failure in patients with hypertensive cardiomyopathy.
Hospital Universitario de Canarias, Department of Cardiology, Tenerife, Spain; Instituto Universitario de Tecnologías Biomédicas, Tenerife, Spain. Electronic address: adrvdg@hotmail.com.
Alberto
A
Dominguez-Rodriguez
Instituto Universitario de Tecnologías Biomédicas, Tenerife, Spain; University of La Laguna, Department of Physiology, Tenerife, Spain.
Pedro
P
Abreu-Gonzalez
Department of Cellular and Structural Biology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Russel J
RJ
Reiter
D009202:Cardiomyopathies / Q000097:blood* / Q000150:complications*; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000209:etiology*; D006801:Humans; D006973:Hypertension / Q000097:blood* / Q000150:complications*; D008297:Male; D008550:Melatonin / Q000097:blood*; D008875:Middle Aged; D011237:Predictive Value of Tests
D008550:Melatonin
Heart failure; Hypertensive cardiomyopathy; Melatonin